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The second messenger cyclic adenosine 5monophosphate (cAMP) has been implicated in controlling meiotic maturation.
To date, there have been no direct measurements of cAMP in living mammalian oocytes. Here, we have used the
fluorescently labelled cAMP-dependent protein kinase A (PKA), FlCRhR, to monitor cAMP in mouse oocytes. In
cumulus-enclosed oocytes, follicle-stimulating hormone (FSH) stimulated an increase in the oocyte [cAMP] that was
prevented by using the gap junction inhibitor, carbenoxolone. The FSH-induced increase in oocyte [cAMP] was suppressed
in a time-dependent manner by prior exposure to ATP, while epidermal growth factor had no effect on basal or stimulated
levels of cAMP. Finally, using confocal microscopy, we show that the regulatory and catalytic subunits of the microinjected
PKA are distributed in a punctate manner with a stronger accumulation in the perinuclear region. On an increase in [cAMP],
in response to phosphodiesterase inhibition or FSH, the catalytic subunit diffused throughout the cytoplasm and germinal
vesicle, while the regulatory subunit remained anchored. These experiments show that increases in cAMP in ovarian
somatic cells are communicated via gap junctions to the oocyte, where it can lead to a redistribution of the catalytic subunit
of PKA. © 2002 Elsevier Science (USA)
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Hormone-induced increases in the second messenger,
cyclic adenosine 5monophosphate (cAMP), regulate a di-
verse range of physiological cellular responses, including
the control of meiotic maturation. These effects are medi-
ated via activation of cAMP-dependent protein kinase A
(PKA), a tetramer consisting of two regulatory (R) and two
catalytic (C) subunits. There are two major isoforms of
PKA, types I and II, which are based on the presence of an RI
or RII subunit. Binding of cAMP by the R subunit leads to
dissociation of the holoenzyme, freeing the catalytic sub-
units for the phosphorylation of substrates (Spaulding,
1993; Francis and Corbin, 1994). There are a number of
mechanisms that control the spatial organisation of signal-
ling through cAMP and PKA. Cell signalling over long
distances is possible because cAMP is sufficiently small to
pass through gap junctions. This proposed gap-junctional
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All rights reserved.communication of cAMP provides a means of coordinating
cells within a tissue to a particular cAMP-mediated func-
tion (Lawrence et al., 1978). Conversely, highly compart-
mentalised cAMP signalling is also possible. This is con-
trolled via interactions with scaffolding proteins such as the
A-kinase anchoring proteins (AKAP) that bind RII, thereby
localising PKA to the proximity of particular substrates
(Herberg et al., 2000; Feliciello et al., 2001; Newlon et al.,
2001). For the most part, investigating the cAMP signalling
pathway has relied on assays using large numbers of cells.
Direct investigation of the spatiotemporal properties of
cAMP signalling in living cells has been made possible
through the development of fluorescent probes for cAMP
(Adams et al., 1991; Zaccolo et al., 2000).
Communication between the oocyte and the surrounding
somatic cells of the ovarian follicle is one physiological
example where gap junction-mediated cAMP signalling is
thought to be important (Downs, 1995). Oocytes are
coupled to cumulus cells via gap junctions at the end of
processes that traverse the zona pellucida (Anderson and
Albertini, 1976; Wright et al., 2001). Gap-junctional com-
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munication is necessary for normal oocyte growth (Brower
and Schultz, 1982) and, in particular, for control of the
meiotic cell cycle (Downs, 1995; Carabatsos et al., 2000;
Albertini et al., 2001; Vozzi et al., 2001). Meiosis in fully
grown mammalian oocytes is arrested at prophase of the
first meiotic division, which is indicated by the presence of
FIG. 1. Monitoring cAMP using FlCRhR in denuded mouse oocytes. Mouse oocytes were injected with FlCRhR (0.2–1 M) and imaged
as described in Materials and Methods. (A) The response to IBMX (10 M). The changes in emission at 520 and 580 nm and the ratio
(520/580) are shown in the top and middle panels, respectively. The bottom panel shows a series of pseudocolour images taken at the time
points indicated. (B) The changes in ratio following the addition of forskolin (10 M) and (C) after microinjection of cAMP (10 M final
concentration). (D) Oocytes were exposed to a series of manipulations to investigate the reversibility of FlCRhR. Oocytes were initially
maintained in 200 M IBMX. Control medium was perfused at the arrow marked with “A” and stopped at “B.” At the arrow marked “C,”
10 M IBMX was added, and at “D,” 1 M forskolin. The responses are representative of four to eight similar experiments.
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a large centrally placed germinal vesicle (GV; nucleus). Meio-
sis resumes if the oocyte is removed from the follicle to a
suitable culture medium, demonstrating that the follicular
environment is responsible for mediating meiotic arrest (Pin-
cus and Enzmann, 1935;Edwards, 1965). A role for cAMP in
this follicle-mediated meiotic arrest is suggested by the obser-
vation that raising intracellular cAMP using (1) membrane
permeable analogues of cAMP, (2) forskolin, and (3) 3-isobutyl-
1-methylxanthine (IBMX), blocks spontaneous in vitro matu-
ration (Cho et al., 1974; Dekel and Beers, 1978; Vivarelli et al.,
1983; Schultz et al., 1983a; Bornslaeger and Schultz, 1985;
Downs, 1995). Also, since follicle components can maintain
meiotic arrest in vitro, it has been suggested that cAMP
derived from the follicle is responsible for maintaining mei-
otic arrest (Tsafriri and Channing, 1975; Dekel and Beers,
1978; Leibfried and First, 1980; Racowsky and Baldwin, 1989).
Attempts have been made to measure whether cAMP is
communicated via gap junctions between the somatic cells
and the oocyte. Previous studies have been performed by
using RIA to measure cAMP in oocytes during stimulation
with agents that increase cAMP. These studies provide an
indication that cAMP may diffuse from the somatic cells to
the oocyte (Vivarelli et al., 1983; Racowsky, 1984; Bornslae-
ger and Schultz, 1985; Salustri et al., 1985). However, it is
not possible to definitively attribute the source of the
increase in oocyte [cAMP] to the somatic cells. For ex-
ample, a follicle-stimulating hormone (FSH)-induced in-
crease in [cAMP] in an oocyte within a cumulus mass can
only be detected when the experiment is performed in the
presence of phosphodiesterase (PDE) inhibitors (Schultz et
al., 1983a; Bornslaeger and Schultz, 1985; Salustri et al.,
1985). The ability to measure [cAMP] in single living cells
provides a means of addressing this question directly in
physiological conditions.
The cAMP fluorosensor, FlCRhR (pronounced flicker), is
PKA, where the catalytic subunits have been labelled with
fluoroscein, and the regulatory subunits with rhodamine. It
relies on fluorescence resonance energy transfer (FRET)
between the labelled subunits in the holoenzyme and the
loss of FRET when it dissociates in the presence of cAMP.
An increase in cAMP, therefore, causes an increase in the
emission ratio of fluoroscein (520 nm)/rhodamine (580 nm).
Furthermore, since it consists of labelled subunits, FlCRhR
also provides a means of determining the effect of an
increase in cAMP on the distribution of the PKA subunits
in living cells. In this study, we use FlCRhR to investigate
the spatiotemporal organisation of the cAMP signalling
pathway in living mammalian oocytes and associated so-
matic cells.
MATERIALS AND METHODS
Collection of Oocytes
Immature oocytes were recovered from MF1 mice that had been
administered pregnant mares’ serum gonadotrophin by intraperito-
neal injection 48 h previously. Mice were killed by cervical
dislocation, and the ovaries were removed and placed into warm
Hepes-buffered M2 (Fulton and Whittingham, 1978) containing 200
M IBMX (M2IBMX) to maintain meiotic arrest. Oocytes were
released from the ovary by scraping the edge of the ovary with a
27-gauge needle. Oocytes with an intact layer of cumulus cells
were collected and washed into fresh drops of M2 covered with oil
(Mineral oil, embryo tested; Sigma). For experiments using cumu-
lus cell-free oocytes (denuded oocytes), the cumulus cells were
removed by repeat pipetting through a narrow-bore pipette.
Assessment of Germinal Vesicle Breakdown
(GVBD)
To examine the effects of various agents on GVBD, denuded
oocytes were collected as described. Oocytes were divided ran-
domly into groups and pipetted into 50-l drops of M2 under oil
containing the desired concentration of IBMX (Sigma), forskolin
(Sigma), milrinone (Calbiochem), or rolipram (Calbiochem). The
oocytes were incubated at 37°C on a hot block, and GVBD was
scored after 6 h.
Microinjection
Immature oocytes were pressure injected with a micropipette
and Narishige manipulators mounted on an inverted Nikon
Diaphot or Leica microscope. Oocytes were placed in a drop of
M2IMBX covered with paraffin oil to prevent evaporation. Pi-
pettes were back-filled with approximately 0.3 L of FlCRhR (20
M stock) in injection buffer (25 mM potassium phosphate, 1 mM
EDTA, 0.5 mM -mercaptoethanol, 2.5% glycerol, pH 7.3) (Mo-
lecular Probes). The oocytes were immobilised by using a holding
pipette, and the injection pipette was pushed through the cumulus
cells (if present) and zona pellucida until it contacted the oocyte
plasma membrane. A brief overcompensation of negative capaci-
tance caused the pipette tip to penetrate the oocyte. A pressure
pulse of 20–30 psi of 0.5 s duration was delivered by using a
picopump (WPI) to inject FlCRhR into the oocyte. Injection vol-
umes were estimated to be 1–5% of the oocyte volume (final
concentration 0.2–1 M) as determined by the cytoplasmic dis-
placement measured during injection by using a calibrated eyepiece
graticule. In some experiments, a second injection of cAMP was
performed 30–90 min after FlCRhR. To allow us to monitor
FlCRhR during the injection of cAMP, the zona pellucida was
removed by a brief exposure to acidified Tyrodde’s medium (Sigma)
and the oocyte was stuck down to the coverslip base of a heated
chamber on the microscope stage. The injection pipette was
inserted, and cAMP in injection buffer (120 mM KCl, 20 mM
Hepes) was injected to a final concentration of 10 M as described
above.
cAMP Measurements
The FlCRhR-injected oocytes were washed out of IBMX prior to
imaging and placed in a heated chamber with a coverslip base on
the stage of Zeiss 100TV. FlCRhR was excited at 488 nm by using
a monochromater. Emission fluorescence was collected through a
520-nm bandpass filter (20 nm bandwidth) and 580 nm long pass
filter housed in a Sutter instruments filter wheel. A micromax
cooled CCD camera was used to collect the emission, which was
recorded and analysed by using MetaFluor and MetaMorph soft-
ware. The raw data were background subtracted before ratioing.
Confocal microscopy was carried out on a BioRad Radiance
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fitted to a Zeiss Axiovert 100TV. FlCRhR was excited by using the
488-nm line of an Argon Laser, and the emission from fluoroscein
and rhodamine was separated by using a 560-nm dichroic mirror.
The fluoroscein emission was collected by using a 520-nm (40 nm
bandwidth) bandpass filter, and rhodamine with a 580-nm long pass
filter. Data were analysed off-line by using MetaMorph software.
RESULTS
The Use of FlCRhR to Monitor cAMP
in Mouse Oocytes
In order to establish that FlCRhR could be used in mouse
oocytes to indicate changes in cAMP, we initially per-
formed experiments using agents that would be expected to
cause changes in the concentration of intracellular cAMP.
FlCRhR-injected denuded oocytes were challenged with
IBMX (Fig. 1A) to inhibit PDEs or forskolin (Fig. 1B) to
stimulate adenylyl cyclase, or were microinjected with
cAMP (Fig. 1C). In each case, high concentrations that are
known to be at the upper end of that required for inhibition
of GVBD were used. The addition of 10 M IBMX to the
chamber containing the oocytes led to an increase in
fluoroscein (520 nm) and a decrease in rhodamine (580 nm)
fluorescence signal. As expected, the ratio of these two
wavelengths shows an increase on addition of IBMX, con-
sistent with an increase in cAMP (Fig. 1A). The mean
increase in the peak 520/580 ratio in response to 10 M
IBMX was 0.22  0.02 ratio units (n  4). Forskolin at 10
M also caused an increase in cAMP in the oocyte, the
maximum change in ratio being 0.26 0.05 ratio units (Fig.
1B; n  9; P  0.05). Finally, we microinjected cAMP into
oocytes that had previously been injected with FlCRhR (Fig.
1C). In five oocytes injected with cAMP, two survived the
double injection and both showed an immediate increase in
the 520/580 ratio. After a few minutes, the ratio returned to
baseline level, indicating that cAMP had been metabolised
(Fig. 1C). This, together with the effects of IBMX, confirms
the previously reported highly active PDE present in mouse
oocytes.
The reversibility of the increase in ratio indicates that the
subunits of the holoenzyme do not scramble with endoge-
nous, unlabelled enzyme (Adams et al., 1993). If such
scrambling of labelled and unlabelled subunits was occur-
ring, then FRET would not be possible when the subunits
reassociate when cAMP decreases. To explore the revers-
ibility of the ratio in more detail, oocytes were repeatedly
exposed to IBMX or forskolin. Figure 1D shows one such
experiment where oocytes, initially maintained in 200 M
IBMX, are perfused with IBMX-free medium. This causes
the predicted decrease in ratio to resting levels. Subsequent
addition and removal of forskolin causes another transient
increase in ratio of similar magnitude to the first. Thus, it
appears that, in mouse oocytes, the endogenous PKA sub-
units do not mix to any significant level with the FlCRhR
subunits.
The Relationship between Meiotic Arrest
and cAMP
To examine the relationship between GVBD and cAMP,
we attempted to monitor cAMP and GVBD in FlCRhR-
injected oocytes treated with agents that modulate cAMP.
However, increasing the concentration of PKA by injecting
FlCRhR proved to inhibit GVBD (9 of 9 oocytes). The
inhibition of GVBD was not due to microinjection itself,
since oocytes injected with the same injection buffer (see
Materials and Methods) underwent GVBD normally (n 6).
Similar effects of FlCRhR on other cAMP-dependent sys-
tems have been reported in ventricular myocytes (Goaillard
et al., 2001) and oocytes of the nemertean worm (Stricker
and Smythe, 2001).
The inhibition of GVBD by FlCRhR prevented correlating
GVBD and cAMP in the same oocyte. We therefore set up
parallel experiments where GVBD was monitored in unin-
jected oocytes and cAMP was monitored in FlCRhR-
injected oocytes in similar conditions. The effects of IBMX
(broad spectrum PDE inhibitor), forskolin (activator of ad-
enylyl cyclase), and isoform-specific PDE inhibitors (Nicol-
son et al., 1991; Tsafriri et al., 1996), milrinone (type III
PDE inhibitor) and rolipram (type IV PDE inhibitor), on
GVBD and cAMP are shown in Fig. 2. Concentration
response curves for the effect of each agent on GVBD were
obtained in 3–6 replicate experiments with 8–20 oocytes in
each replicate. These studies reveal that IBMX, forskolin,
and milrinone all inhibit GVBD in a dose-dependent man-
ner with 50% inhibition at approximately 3, 0.1, and 1 M,
respectively. Rolipram had no effect on GVBD at concen-
trations up to 100 M, suggesting that type IV PDE is not
present in mouse oocytes. The effectiveness of milrinone,
maximum inhibition at 5 M, suggests that the type III
PDE is the major isoform present in mouse oocytes.
Concentrations of IBMX and forskolin that were effective
at inhibiting GVBD all caused a significant increase in
oocyte cAMP, as indicated by an increase in the 520/580
ratio (Fig. 2). IBMX (10 M) caused an increase of 0.22 
FIG. 2. Inhibition of GVBD correlates with increases in cAMP. GVBD was monitored in the presence of increasing concentrations of
forskolin, IBMX, milrinone, and rolipram (left panels). The effect of an inhibitory concentration of each agent (except rolipram) is shown
in the panels on the right. Concentrations effective at inhibiting GVBD also showed an increase in the 520/580 ratio. Note that the type
IV PDE inhibitor, rolipram, had no effect on GVBD or cAMP. Each point represents the mean and standard error for 3–6 replicate
experiments with 8–20 oocytes in each replicate. Traces showing the effect on cAMP levels are from single oocytes representative of records
obtained for 2–9 oocytes.
444 Webb et al.
© 2002 Elsevier Science (USA). All rights reserved.
445cAMP in Mammalian Oocytes
© 2002 Elsevier Science (USA). All rights reserved.
FIG. 3. Activation of FSH receptors on the cumulus cells results in an increase in cAMP in the oocyte. Cumulus-intact oocytes were
injected with FlCRhR to examine the effects of FSH on cAMP in the oocyte. In (A), one such experiment is shown. The addition of FSH
leads to an increase in the 520/580 ratio. The pseudocolour images are shown below. The first image is a combined bright field and
fluorescence image to show the localisation of the FlCRhR in the cumulus–oocyte complex. The subsequent images are taken at the time
points indicated in the trace. There was a variable delay between the application of FSH (1 Uml1) and the increase in [cAMP] in the oocyte.
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0.02 in the 520/580 ratio (n 4), while forskolin (100 nM to
1 M) resulted in an increase of 0.12  0.02 (n  4).
Consistent with the effects of the isoform-specific PDE
inhibitors, rolipram had no effect on cAMP levels, while
milrinone (100 and 10 M) caused an increase in FlCRhR
ratio of 0.28  0.02 (n  9; P  0.001) and 0.18  0.01 ratio
units (n  5; P  0.001), respectively. Together, these data
confirm that cAMP plays a role in inhibiting GVBD and
that FlCRhR is providing physiologically relevant measures
of cAMP.
Hormone-Induced Changes in cAMP, Diffusion
from the Somatic Cells to the Oocyte
One hypothesis for the maintenance of meiotic arrest in
intact follicles proposes that cAMP is transferred via gap
junctions from somatic cells to the oocyte. Previous mea-
surements of gap junction-mediated transfer of cAMP to the
oocyte have been carried out by using RIA. As discussed in
the Introduction, this technique has some serious draw-
backs, including the requirement to inhibit PDEs during
the experiment. FlCRhR provides the first real opportunity
to investigate gap junction-mediated changes in cAMP in
the oocyte. Cumulus-enclosed oocytes were microinjected
with FlCRhR, and cAMP production was stimulated in
cumulus cells with FSH. After a variable delay from the
time of FSH addition, the 520/580 ratio increased 0.20 
0.03 (n  8; P  0.05) ratio units above baseline in response
to 1 UmL1 FSH (Fig. 3A). The cumulus cells were neces-
sary for the increase in the FlCRhR ratio, since FSH had no
effect on denuded oocytes (not shown). Thus, FSH can
stimulate an increase in cAMP in the oocyte via its effect
on the cumulus cells.
The variable delay in the time required for the FSH-
induced increase in cAMP in the oocyte was further exam-
ined by plotting the delay as a function of the rate of rise of
the 520/580 ratio (Fig. 3B). This graph reveals two features
of the cAMP response: first, the delay in response to FSH
compared with IBMX and forskolin; and, second, a lack of
any relationship between the rate of rise and the delay to
the onset of the response.
The Role of Gap Junctions in Hormone-Mediated
Changes in cAMP
The increase in cAMP measured in the oocyte after
application of FSH to the cumulus–oocyte complex may
arise through two different mechanisms: first, the genera-
tion of a messenger from the cumulus cells that may act in
a paracrine fashion on cAMP-generating receptors on the
oocyte plasma membrane; and, second, via diffusion
through gap junctions between the cumulus cells and the
oocyte. To distinguish these possibilities, we have used the
gap junction inhibitor, carbenoxolone (100 M) (Davidson
et al., 1986; Davidson and Baumgarten 1988; Goldberg et
al., 1996) in an effort to inhibit direct passage of cAMP from
cumulus cells to the oocyte. In previous experiments, we
have established that carbenoxolone (100–500 M) effec-
tively inhibited the diffusion of fluoroscein from the oocyte
to the cumulus cells (Webb et al., 2002). After pretreatment
with carbenoxolone, the addition of FSH (1 UmL1; Fig. 4)
caused no change in the FlCRhR ratio (n  7). The oocytes
remained capable of generating cAMP since a subsequent
addition of IBMX (100 M), caused the expected increase in
the florescence ratio (n  3). Thus, patent gap junctions
were necessary for FSH-induced increases in cAMP to be
reported in the oocyte.
Cross Talk between Ovarian Signalling Pathways
and Oocyte [cAMP]
Recently, we demonstrated that P2-receptor agonists,
ATP and UTP, stimulate Ca2 release in cumulus cells that
propagate to the oocyte. Since there is cross talk between
Ca2 and cAMP signalling systems and because Ca2
changes in granulosa cells have been reported to modulate
the responsiveness to gonadotrophins, we tested the effect
of ATP on FSH-induced cAMP increases in the oocyte. ATP
(1 mM) had no effect on basal cAMP levels during a 15-min
incubation. Subsequent addition of FSH (1 UmL1), after
the 15-min incubation with ATP, resulted in an increase in
cAMP that was significantly reduced (0.08  0.02 ratio
units; n 4; Fig. 5A) compared with controls not previously
exposed to ATP (P  0.01). To determine the time course of
the inhibition, cumulus-enclosed oocytes were preincu-
bated with ATP for 5 min prior to application of ATP. Such
short preincubations had no effect on the subsequent re-
sponse to FSH (0.17 0.02 ratio units; n 5; Fig. 5A). These
data suggest that ATP suppresses the FSH-induced increase
in cAMP in the oocyte and that the inhibition takes
between 5 and 15 min to develop.
Another signalling pathway implicated in regulating fol-
licle and oocyte function is epidermal growth factor (EGF).
EGF receptors are expressed on mouse granulosa and cumu-
lus cells (J.C., unpublished observations), and it and FSH are
the only agonists that are known to override cAMP-
mediated meiotic arrest in vitro (Downs et al., 1988). To
determine whether EGF-induced effects are mediated via
changes in cAMP, we have applied EGF (20 ngmL1) to
FlCRhR-injected oocytes in intact cumulus–oocyte com-
In (B), the delay in response to FSH is plotted as a function of the rate of rise (red circles). For comparison, the delay after application of
forskolin (100 M; blue squares) and milrinone (10 M; black triangles) to denuded oocytes is shown. The responses are representative of
six to nine similar experiments.
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plexes. EGF had no effect on the FlCRhR ratio, while a
subsequent application of FSH stimulated the expected
ratio increase (0.20  0.06 ratio units; n  3; Fig. 5B). Thus,
EGF-mediated effects are independent of cAMP, and EGF
does not influence the ability of FSH to modulate the
[cAMP] in the oocyte.
Subcellular Distribution of FlCRhR and
Redistribution of the Catalytic Subunit When
cAMP Increases
Previous studies have reported that an increase in cAMP
leads to redistribution of the catalytic subunit such that it
diffuses into the nucleus (Harootunian et al., 1993). To
determine whether the cAMP changes we generate in
oocytes can lead to the redistribution of the catalytic
subunit into the GV, we monitored the distribution of the
catalytic and regulatory subunits in the green and red
channels of a confocal microscope (Fig. 6). In the absence of
cAMP, the holoenzyme was excluded from the nucleus as
has been reported in other cell types. Close examination of
the distribution of cytoplasmic fluorescence revealed that
FlCRhR was not, as described previously, distributed uni-
formly in the cytoplasm. Both subunits showed a punctate
distribution throughout the cytoplasm with larger accumu-
lations of fluorescence around the GV (Figs. 6A and 6F).
On addition of IBMX (100 M) to increase cAMP, the
catalytic subunit (green channel) underwent a dramatic
change in distribution, from punctate to homogeneous,
while the regulatory subunit (red channel) remained fixed
in a punctate pattern (Figs. 6A and 6F). To quantify this
change, we measured the mean pixel intensity (Fig. 6B) and
standard deviation (SD) (Fig. 6C) in regions of interest (ROI)
around the perinuclear cytoplasm (black line) and in the GV
(red line). Analysis of changes in fluorescence due to redis-
tribution need to be treated with caution due to the addi-
tional changes induced by FRET and photobleaching. How-
ever, the loss of FRET when cAMP increases will only
result in an underestimation of the decrease in mean pixel
intensity resulting from redistribution of the catalytic sub-
unit. Also, the mean pixel intensity in the GV is indepen-
dent of FRET because the regulatory subunit does not enter
the GV. Thus, these measurements can be made without
concern that the data may be confounded due to FRET. This
analysis shows that the mean pixel intensity (Fig. 6B) and
SD (Fig. 6C) of fluorescence from the catalytic subunit
decrease in the perinuclear region and increase in the GV in
response to the increase in cAMP, consistent with a redis-
tribution of the catalytic subunit. The ratio of the SD of the
mean pixel intensity in the cytoplasm, where the catalytic
subunit is aggregated, and GV, where it is homogeneous,
provides normalised values independent of the amount of
FlCRhR. Redistribution of the catalytic subunit from sites
of accumulation to a homogeneous distribution predicts
that the ratio would approach unity. These data show this
to be the case (Fig. 6D), and this analysis performed on five
individual oocytes reveals that IBMX causes a significant
increase in the ratio from 0.68 0.02 to 0.86 0.02 (Fig. 6E;
P  0.01; paired Student’s t test).
To determine whether physiological, gap junction-
mediated increases in cAMP cause a similar redistribution,
we monitored changes in the distribution of the catalytic
and regulatory subunits after application of FSH to
cumulus-enclosed oocytes. Prior to application of FSH, the
distribution is similar to that seen in denuded oocytes (Fig.
7). The punctate distribution of the subunits is less clear
since imaging through the cumulus cells leads to some loss
of resolution. On addition of FSH, the rhodamine-labelled
regulatory subunit remains anchored, particularly in the
perinuclear region, while the fluoroscein-labelled catalytic
subunit diffuses into the cytoplasm and shows a homoge-
neous distribution (Fig. 7A) (n  3). Analysis similar to that
described above for IBMX is consistent with FSH, causing a
redistribution of the catalytic subunit of FlCRhR (see Fig.
7B). Taken together, these observations suggest that the
FlCRhR holoenzyme is anchored to cytoplasmic structures
and that, on activation by cAMP, the catalytic subunit is
released and diffuses throughout the cytoplasm and GV.
DISCUSSION
FlCRhR Is a Reliable Reporter of cAMP
Concentration in Mammalian Oocytes
FlCRhR has been used as a probe for cAMP in a variety of
cell types, including fibroblasts (Adams et al., 1991), neu-
rons (Bacskai et al., 1993), and most recently, oocytes from
the nemertean worm (Stricker and Smythe, 2001). Experi-
FIG. 4. Inhibition of gap-junctional communication inhibits FSH-
induced increases in cAMP in cumulus-enclosed oocytes. FlCRhR-
injected cumulus-enclosed oocytes were treated with carbenox-
olone (100 M). Carbenoxolone had no effect on the basal level of
cAMP in the oocyte; however, the response to FSH (1 UmL1) was
completely abolished. The responses are representative of seven
similar experiments. The subsequent addition of IBMX (100 M) to
three of the carbenoxolone-treated complexes to directly increase
[cAMP] caused the predicted increase in the 520/580 ratio.
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ments described here represent the first reports of direct
measurement of cAMP in living mammalian oocytes. A
number of observations indicate that FlCRhR is reliably
reporting changes in [cAMP] in oocytes. First, the FlCRhR
data support previous results with RIA, showing that IBMX
and forskolin increase [cAMP]. Second, cAMP injection also
causes an increase in the 520/580 ratio indicative of an
increase in cAMP. Third, concentrations of agents that
increase cAMP also inhibit GVBD; and finally, isoform-
specific PDE inhibitors are only effective if the type III
isoform is targeted. FlCRhR also provides a reliable mea-
sure of decreases in [cAMP], since the ratio returns to
baseline when the stimulus for the cAMP increase is
removed. The lack of any significant scrambling between
the subunits of endogenous PKA and FlCRhR is consistent
with findings in other cells. This may reflect the high
concentration of FlCRhR relative to endogenous PKA
(Goaillard et al., 2001) or a high affinity of the particular
isoforms of the subunits of the endogenous PKA and
FlCRhR we are using. Together, these observations demon-
strate that FlCRhR can be used as a reporter of changes in
the concentration of cAMP in mammalian oocytes.
FlCRhR does come with some inherent problems that
have been discussed at length elsewhere (Adams et al.,
1991, 1993). Calibration and quantification of the absolute
[cAMP] proved difficult due to previously reported prob-
lems, such as variable baseline values and batch-to-batch
variation (Adams et al., 1993; Goaillard et al., 2001; Stricker
and Smythe, 2001). As a result, [cAMP] is often expressed as
the 520/580 ratio, as we have done here. Previously ob-
tained calibration curves for FlCRhR (Adams et al., 1991)
suggest that a 1.4-fold change in ratio represents a change in
cAMP over the range of 50 nM to 1–5 M. In our studies, we
see a similar maximal 1.3- to 1.4-fold increase in ratio,
suggesting that cAMP changes in mouse oocytes are over a
similar concentration range. Previous RIA measurements of
[cAMP] in oocytes have ranged from around 500 nM to 1–2
M in mice, hamsters, and rats (Schultz et al., 1983b;
Racowsky, 1984, 1985); to upwards of 8 M in the sheep
(Moor and Heslop, 1981). The discrepancy between RIA and
FlCRhR estimates of [cAMP] has been a consistent finding
in other cell types (Adams et al., 1991, 1993) and most
likely reflects the difference between total and free cAMP.
The second limitation is that the levels of FlCRhR required
to detect changes in [cAMP] are sufficient to inhibit GVBD.
Similar effects on cell physiology have been reported in
smooth muscle cells (Goaillard et al., 2001) and nemertean
worm oocytes (Stricker and Smythe, 2001), although in
some cells, cAMP-sensitive events are not apparently af-
fected (Bacskai et al., 1993). Increasing the availability of
PKA for activation by cAMP is the most likely explanation
for these effects in mouse oocytes and other cell types.
From Somatic Cells to Germ Cells: Gap Junctional
Communication of cAMP
Our studies show that FSH causes an increase in cAMP in
the oocyte that is dependent upon patent gap junctions with
neighbouring cumulus cells. This suggests that the cAMP
increase in the oocyte is a result of cAMP diffusing from the
cumulus cells to the oocyte. Alternative explanations can-
not be completely discounted. It is feasible that, in addition
to cAMP, FSH stimulates the production of an additional
small messenger molecule that is able to modulate oocyte
cAMP levels by inhibiting the PDE or stimulating adenylyl
cyclase. However, to our knowledge, no evidence for this
form of signalling has been reported in other cell types,
while indirect evidence for cAMP diffusing through gap
junctions has been described in some classic experiments.
Cocultures of granulosa cells and myocytes elicited cell
type-specific, cAMP-dependent functions in response to
hormones that exclusively stimulated receptors on either
cell type (Lawrence et al., 1978).
The kinetics of diffusion of cAMP from cumulus to
oocyte cannot be readily established because we were not
able to monitor cAMP levels in the cumulus cells and
oocyte simultaneously. One feature of FSH-induced in-
FIG. 5. ATP but not EGF modulates cAMP in cumulus-enclosed
oocytes. (A) FlCRhR-injected oocytes were exposed to ATP (1 mM),
5 and 15 min before application of FSH 1 UmL1. The data are
presented so that the time of ATP addition is the same for both
oocytes. Note that ATP has no effect on the ratio but significantly
suppresses subsequent response to FSH in a time-dependent man-
ner. In contrast, EGF has no effect on basal or FSH-stimulated
levels of cAMP (B).
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creases in cAMP in the oocyte is that the increase was often
delayed compared with that elicited by PDE inhibitors. The
additional time between application of agonist and increase
in cAMP may be due to the time taken for production of
cAMP in the cumulus cells and for diffusion from the
cumulus cells to the oocyte. If diffusion was the complete
answer, it might be expected that where diffusion into the
oocyte was slow, the rate of rise in the oocyte would also be
slow. However, this does not appear to be the case. The
time to response is independent of the rate of rise, suggest-
FIG. 6. Increases in cAMP cause redistribution of the catalytic subunit of PKA. FlCRhR-injected oocytes were examined on a confocal
microscope. The time course of the change in FlCRhR distribution in response to IBMX is shown in a region around the GV (A). The red
panels show the 580-nm emission (regulatory subunit), and the green panel the 520-nm emission (catalytic subunit). The addition of IBMX
(100 M) is indicated by the arrows. (B, C) The effect of IBMX addition on the mean pixel intensity and SD of the pixel intensity of the
520-nm emission in ROIs in the perinuclear cytoplasm and GV are plotted. The data are taken from the ROIs shown in the insert. (D) The
GV/cytoplasm ratio of the SD is plotted against time. Note the ratio approaches 1 after redistribution is induced. (E) The average
GV/cytoplasm ratio of SD before and after the addition of IBMX (n  5, mean and SEM; P  0.01). (F) The change in the distribution of
fluorescence is shown as surface topology plots before (left panel) and after (middle panel) addition of IBMX. The right panel shows the
intensity profile of a line through the centre of the GV before (black) and after (red) IBMX.
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ing that a component of a positive feedback system may be
operating in the mechanism for increasing oocyte [cAMP].
A threshold effect in the generation of cAMP in cumulus–
oocyte complexes has been suggested previously (Bornslae-
ger and Schultz, 1985). It may be that such a positive
feedback loop, at the level of the G-protein or adenylyl
cyclase in the cumulus cells, contributes to the variable
times between addition of FSH and the increase in [cAMP]
in the oocyte.
The ability of cAMP to diffuse from cumulus cells to the
oocyte has been an important concept, since it was first
proposed that cAMP from the cumulus cells maintains
meiotic arrest and that meiotic resumption is caused by
disrupting this communication (Dekel and Beers, 1978,
1980). Original experiments designed to test this hypothesis
involved the measurement of cAMP using RIA in cumulus-
free and cumulus-enclosed oocytes exposed to IBMX or
forskolin (Vivarelli et al., 1983; Racowsky, 1984; Bornslae-
ger and Schultz, 1985; Salustri et al., 1985). Oocyte cAMP
reached higher levels in the presence of cumulus cells than
in their absence, suggesting that at least some of the cAMP
may be of cumulus cell origin. However, it is also possible
that the removal of cumulus cells interferes with the ability
of the oocyte to generate cAMP. Similar experiments using
FSH and cumulus cell-enclosed oocytes have also proved
inconclusive. Initial experiments suggested that FSH did
not lead to an increase in cAMP in the oocyte (Schultz et
al., 1983c). Subsequently, it was found that the addition of
FSH in the presence of PDE inhibitors did lead to an
increase in oocyte cAMP in cumulus-intact but not
cumulus-free oocytes (Bornslaeger and Schultz, 1985; Salus-
tri et al., 1985). Thus, measurement of cAMP diffusion from
cumulus cells to the oocyte has only been reported in
unphysiological conditions where [cAMP] has already been
elevated several-fold by PDE inhibitors. Our data using
FlCRhR show directly that FSH induces an increase in
cAMP in the oocyte in physiological conditions.
The ability of hormonal effects on the somatic cells to
change the [cAMP] in the oocyte supports the idea that
cAMP is important for regulating meiosis. The addition of
FSH to isolated cumulus–oocyte complexes delays the rate
of GVBD for several hours (Salustri and Siracusa, 1983),
consistent with its effects on cAMP in the oocyte. Diffusion
of cAMP to the oocyte may also have important implica-
tions for understanding the resumption of meiosis. In intact
follicles, an increase in [cAMP] induced by LH, forskolin, or
IBMX leads to the resumption of meiosis (Tsafriri et al.,
1972; Lindner et al., 1977; Dekel and Sherizly, 1985; Yo-
shimura et al., 1992a,b). How cAMP stimulates meiotic
maturation in intact follicles remains unclear. One model
suggests that LH-induced increases in [cAMP] may disrupt
gap junctions, leading to a decrease in oocyte cAMP (Gilula
et al., 1978; Larsen et al., 1986, 1987). Alternatively, it has
been suggested that LH leads to the production of an
activating signalling molecule that overrides cAMP-
mediated meiotic arrest (Eppig and Downs, 1987; Downs et
al., 1988). Experiments using FlCRhR in oocytes arrested in
FIG. 7. FSH induces redistribution of the catalytic subunit. (A) The time course of the change in FlCRhR distribution in a cumulus–oocyte
complex (see bright field) in response to FSH (labels as for Fig. 6). (B) The changes in fluorescence intensity in the regions of interest depicted
on the insert are shown in the left panel. The SD of the mean pixel intensity in the same regions is shown in the middle panel and the
GV/cytoplasm ratio of the SD in the right panel. Data are representative of three oocyte–cumulus complexes.
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follicles in culture (Smitz and Cortvrindt, 2002) may help to
determine which, if either, of these models is right.
One signalling molecule that may play a role in regulat-
ing somatic cell–oocyte interactions is ATP. We have
recently shown that ATP stimulates Ca2 increases in
cumulus cells that propagate to the oocyte via gap junctions
(Webb et al., 2002). In the present study, we find that
previous exposure to ATP significantly attenuates the FSH-
induced increase in cAMP in the oocyte. It is not yet clear
whether the effects are mediated by decreasing the ability of
FSH to produce cAMP (Tai et al., 2001) or by an inhibition
of the permeability of gap junctions. Such an inhibition of
the ability of FSH to increase oocyte [cAMP] is one possible
mechanism for releasing the oocyte from cAMP-mediated
meiotic arrest. In other circumstances, such as regulation of
follicle selection, ATP, perhaps arising from hypoxic or
dying cells in the follicle, may decrease the sensitivity of
the somatic cells to gonadotrophins, with the result that
the follicle is not able to establish dominance and undergo
ovulation.
cAMP Leads to Dynamic Changes in the
Distribution of the Catalytic Subunit of PKA
In oocytes, the FlCRhR holoenzyme was found localised
to discrete cytoplasmic structures with a larger aggregation
around the GV. Such localisation of FlCRhR had not been
reported in previous studies, probably as a result of using
FlCRhR with the cytosolic RI regulatory subunit. The
FlCRhR used in our experiments contained the RII regula-
tory subunit, which is known to localise to AKAPs that
target PKA to specific sites in the cytoplasm (Rubin, 1994;
Pawson and Scott, 1997; Herberg et al., 2000). The physio-
logical significance of AKAPs in oocytes is not clear since
biochemical and pharmacological data suggest that the
oocytes express predominantly the RI isoform (Downs and
Hunzicker, 1995). Scaffolding proteins, however, confer
remarkable specificity of function (Buxton and Brunton,
1983; Pawson and Scott, 1997), suggesting that even low
levels of RII may be functionally important. Given the role
of cAMP in the regulation of GVBD, it is tempting to
speculate that the perinuclear accumulations of PKA may
be important in GVBD. Certainly, increases in cAMP in
response to FSH or IBMX caused a dramatic redistribution
of the C subunit from the perinuclear region and cytoplas-
mic structures to the cytosol and GV.
These studies provide the first demonstration of the
dynamic redistribution of anchored PKA in living cells.
Most studies have demonstrated interaction with AKAPs
by using overlay assays (Lohmann and Walter, 1984; Carr et
al., 1991). More recently, using FRET, real-time observa-
tions of RII interacting with Ht31, the RII binding domain
of AKAPs, have been observed in living cells (Ruehr et al.,
1999). Our experiments extend these observations, allowing
the direct visualisation of the anchored holoenzyme and the
dynamics of its activation on an increase in cAMP. These
studies suggest that FlCRhR, when used in this confocal
mode, will prove a powerful tool for investigating the
compartmentalisation of the cAMP signalling pathway.
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